Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension - sprookjes - yvandenbroek - TriplyDB

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

http://www.wikidata.org/entity/Q34627552

about

Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.A review of recent developments and applications of morphometry/stereology in lung research.Endothelial dysfunction and vascular disease - a 30th anniversary update.Exogenous NAD(+) administration significantly protects against myocardial ischemia/reperfusion injury in rat model.Update on novel targets and potential treatment avenues in pulmonary hypertension.Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation.Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.Endothelial-dependent dilation following chronic hypoxia involves TRPV4-mediated activation of endothelial BK channels.Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia.

P2860

Q36399859-B8DCDA7B-0B4A-4160-B215-7D49CD948915 Q36698712-3E9B5720-15B4-4A31-B702-5F2D661F4696 Q37139542-F44A4C7E-2FE7-4D2D-AEFC-E1EE2BDD81E3 Q37668859-774BDB39-9ECD-48BA-81ED-225D4B6ECEE1 Q38549538-96242C4E-1F17-4F24-A3FD-40577CEFAA0D Q38680112-56EB9593-79A9-40ED-A319-3452B75EB7F0 Q41003426-4B198170-D2D5-4E50-9FCE-30F3F6248FB9 Q42784219-69628A80-4786-4671-8D4A-DB2AC774A932 Q46280886-283A1F92-5115-466E-AADE-6DC29BCD5BDF Q48273119-5D72FC65-92FC-46B9-8F19-210C5B244534 Q49588902-FC2CD7F0-B3CB-40EA-9D8D-C3E215EA0885 Q49975788-D9B081F9-18E8-4F43-9E54-056E5C81FF93 Q50334242-1FB9DCC6-9004-402C-8AAA-90C26FC8B435 Q55188252-FA8669FB-6B37-44EE-A450-62EF49E5B4C8

P2860

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

http://www.wikidata.org/entity/Q34627552

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@ast

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@en

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@nl

type

label

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@ast

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@en

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@nl

prefLabel

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@ast

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@en

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@nl

P1433

Q34627552-967DFDA9-FE7D-42DF-8935-5BF736BA4244

P1476

Q34627552-98F2FED9-91D3-4FC1-BE83-D965AF094D5E

P2093

Q34627552-001DB3EA-065E-47A3-81F5-2450861D9C43

Q34627552-159EE25F-DC02-40CD-8659-205A7833B32C

Q34627552-174D2C25-3C97-4D92-AA4C-FC8FEB4E0363

Q34627552-6BC38726-0201-42A4-941F-7F19EC281C7F

Q34627552-AC5768EA-A983-47B2-AC8A-63E7A6154E32

Q34627552-C320C4F7-0B8E-4CAD-9D47-53A5BDEACCA8

Q34627552-D18311C2-5970-42F4-8912-1A79A7A33A21

Q34627552-E9854F70-0469-40B4-B1A8-CA56CB1D361F

Q34627552-FA10233D-B725-4EA1-9545-A6C0CAAB8447

P2860

Q34627552-090CA7AA-2952-49AA-B3DF-40198E3BDADB

Q34627552-118B7E32-21F0-4F93-8333-CC0B82F02B06

Q34627552-1950AA62-8FA6-4956-9A55-F878BE60ED6D

Q34627552-1CBC819B-2BAC-4A66-98BF-56FB0515069A

Q34627552-1FC965C5-E556-472C-B42C-C2FEF3FB013D

Q34627552-22E22259-25E5-4C1C-B12A-D7D27F6302EC

Q34627552-26AB5C43-FC13-4362-A16E-D484F2015AC6

Q34627552-35B34A9A-F17B-4F34-9781-14852632D09C

Q34627552-398BA285-0120-4B8D-9A75-181EF2A18062

Q34627552-479A557A-C850-4968-9A98-B0187900F9DF

P304

Q34627552-C44F529B-51EB-4FE1-98F3-418582EED5DF

P31

Q34627552-B3A5D572-AA9C-4BAB-9C6D-BBC15352AC40

P356

Q34627552-BF0A24A3-DBB4-4ABD-8625-D9ED2652E485

P433

Q34627552-9817B8D6-EB87-4F22-AF68-2AFC243F6FCD

P478

Q34627552-6D6D625F-E748-48F8-B9F2-423D4AF83F02

P50

Q34627552-41302701-B0A9-4F15-98DF-B661DBF458AF

Q34627552-857A7831-DE0B-4FD4-ADDE-04CA53ABADFA

P577

Q34627552-D141036A-08A7-40BC-BDFE-A150E421C411

P5875

Q34627552-C93E7FEC-83E5-42F1-9DB0-A1961CB8CCCC

P698

Q34627552-5701E2C4-B2E2-4D8A-85D3-845D137E5353

P921

Q34627552-6E1278C2-BAD1-4E11-B942-F8967FB4B657

P932

Q34627552-F8B778C7-9697-42C1-85CD-3E248223818D

P356

AJPLUNG.00096.2014

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension

@en

P2093

Crystal Woods

http://www.w3.org/2001/XMLSchema#string

David G Harrison

http://www.w3.org/2001/XMLSchema#string

David Irwin

http://www.w3.org/2001/XMLSchema#string

Eva Nozik-Grayck

http://www.w3.org/2001/XMLSchema#string

Joann M Taylor

http://www.w3.org/2001/XMLSchema#string

Kurt R Stenmark

http://www.w3.org/2001/XMLSchema#string

Leah R Villegas

http://www.w3.org/2001/XMLSchema#string

Richard D Johnson

http://www.w3.org/2001/XMLSchema#string

Susan M Majka

http://www.w3.org/2001/XMLSchema#string

P2860

Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface

Human copper-containing superoxide dismutase of high molecular weight

Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice.

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.

Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.

Biopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice.

Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase.

Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension.

Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia.

P304

L868-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00096.2014

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn N. Farrow

Richard Benninger

P577

2014-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267043782

http://www.w3.org/2001/XMLSchema#string

P698

25326578

http://www.w3.org/2001/XMLSchema#string

P921

P932

4254965

http://www.w3.org/2001/XMLSchema#string